302 related articles for article (PubMed ID: 29990746)
1. The relationships between cytochromes P450 and H
Albertolle ME; Peter Guengerich F
J Inorg Biochem; 2018 Sep; 186():228-234. PubMed ID: 29990746
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous detection of NADPH consumption and H
Morlock LK; Böttcher D; Bornscheuer UT
Appl Microbiol Biotechnol; 2018 Jan; 102(2):985-994. PubMed ID: 29150709
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.
Mishin V; Heck DE; Laskin DL; Laskin JD
Toxicol Sci; 2014 Oct; 141(2):344-52. PubMed ID: 25061110
[TBL] [Abstract][Full Text] [Related]
4. Peroxygenase reactions catalyzed by cytochromes P450.
Shoji O; Watanabe Y
J Biol Inorg Chem; 2014 Jun; 19(4-5):529-39. PubMed ID: 24500242
[TBL] [Abstract][Full Text] [Related]
5. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
6. Enabling Peroxygenase Activity in Cytochrome P450 Monooxygenases by Engineering Hydrogen Peroxide Tunnels.
Zhao P; Kong F; Jiang Y; Qin X; Tian X; Cong Z
J Am Chem Soc; 2023 Mar; 145(9):5506-5511. PubMed ID: 36790023
[TBL] [Abstract][Full Text] [Related]
7. CYP102A1 peroxygenase catalyzed reaction via in situ H
Hardiyanti Oktavia FAR; Nguyen NA; Park CM; Cha GS; Nguyen THH; Yun CH
J Inorg Biochem; 2023 May; 242():112165. PubMed ID: 36848686
[TBL] [Abstract][Full Text] [Related]
8. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
Vaz AD; Pernecky SJ; Raner GM; Coon MJ
Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the cytochrome P450 peroxygenase enzymes.
Munro AW; McLean KJ; Grant JL; Makris TM
Biochem Soc Trans; 2018 Feb; 46(1):183-196. PubMed ID: 29432141
[TBL] [Abstract][Full Text] [Related]
10. The oxidative inactivation of cytochrome P450 in monooxygenase reactions.
Karuzina II; Archakov AI
Free Radic Biol Med; 1994 Jan; 16(1):73-97. PubMed ID: 8299999
[TBL] [Abstract][Full Text] [Related]
11. Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119.
Başlar MS; Sakallı T; Güralp G; Kestevur Doğru E; Haklı E; Surmeli NB
J Biol Inorg Chem; 2020 Oct; 25(7):949-962. PubMed ID: 32924072
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of copper (II) on the cytochrome P450 enzymes and NADPH-cytochrome P450 reductase: inhibition of cytochrome P450-catalyzed reactions by copper (II) ion.
Kim JS; Ahn T; Yim SK; Yun CH
Biochemistry; 2002 Jul; 41(30):9438-47. PubMed ID: 12135366
[TBL] [Abstract][Full Text] [Related]
13. Heme and apoprotein modification of cytochrome P450 2B4 during its oxidative inactivation in monooxygenase reconstituted system.
Karuzina II; Zgoda VG; Kuznetsova GP; Samenkova NF; Archakov AI
Free Radic Biol Med; 1999 Mar; 26(5-6):620-32. PubMed ID: 10218650
[TBL] [Abstract][Full Text] [Related]
14. Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition.
Albertolle ME; Kim D; Nagy LD; Yun CH; Pozzi A; Savas Ü; Johnson EF; Guengerich FP
J Biol Chem; 2017 Jul; 292(27):11230-11242. PubMed ID: 28533430
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic reaction of hydrogen peroxide-dependent peroxygenase cytochrome P450s: kinetic deuterium isotope effects and analyses by resonance Raman spectroscopy.
Matsunaga I; Yamada A; Lee DS; Obayashi E; Fujiwara N; Kobayashi K; Ogura H; Shiro Y
Biochemistry; 2002 Feb; 41(6):1886-92. PubMed ID: 11827534
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
Guengerich FP; Wilkey CJ; Phan TTN
J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
18. Bioengineering of Cytochrome P450 OleT
Reinhard FGC; Lin YT; Stańczak A; de Visser SP
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526971
[TBL] [Abstract][Full Text] [Related]
19. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes.
Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ
Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418
[TBL] [Abstract][Full Text] [Related]
20. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
Locuson CW; Wienkers LC; Jones JP; Tracy TS
Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
